News

Left to right: Anne Lennon Bird, Svein Olaf Olsen and Astri Arnesen.

Unpacking Wave’s PRECISION-HD2 huntingtin-lowering trial announcement

Just before the new year, Wave announced that the drug in the PRECISION-HD2 trial had successfully lowered the concentration of ...
Read More

Trial Finder Launched in Europe

This Christmas, we launched the first HD Trial Finder in Europe. HD Trial Finder is a platform developed to make ...
Read More

2019 ends with exciting results from Wave PRECISION-HD2 trial!

Today, December 30, Wave announced the first preliminary results from the their study PRECISION-HD2 . So far the results are ...
Read More

First human gene therapy trial in Huntington’s disease

UniQure announces key details of its planned trial to assess the safety and ability of AMT-130 gene therapy to lower ...
Read More

European Huntington heights met at Lund summit

A few weeks ago The Huntington Disease Center in Lund, Sweden, welcomed researchers, clinicians and representatives from patient organizations in ...
Read More

The Huntington Challenge

November 30, the “Huntington Challenge” started. Since then, the challenge has been spread across Europe. The aim is to raise ...
Read More

Two years with HD on the Move

If you have attended any of our conferences, you have probably noticed ‘HD on the Move’ in the programme. The ...
Read More

EHA19: An Amazing Conference

October 4-6, the European Huntington Association conference was held in Bucharest. 220 professionals and family members were gathered in Romania ...
Read More

HD-COPE: Meeting with European patient representatives

Thursday afternoon, October 3, the European HD-COPE members and the European Huntington Association board met in Bucharest, Romania. They talked ...
Read More
Loading...